KPX Lifescience.Co.Ltd (114450) — Free Cash Flow Generation Index
KPX Lifescience.Co.Ltd (114450) has a Free Cash Flow Generation Index of 0.92x as of September 2025. Free cash flow of ₩3.05 Billion represents 1% of operating cash flow (₩3.33 Billion). Read KPX Lifescience.Co.Ltd (114450) total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
KPX Lifescience.Co.Ltd Free Cash Flow Generation Index (2014–2024)
Historical FCF Generation Index trend for KPX Lifescience.Co.Ltd across 10 annual periods. Explore KPX Lifescience.Co.Ltd capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for KPX Lifescience.Co.Ltd (2014–2024)
Year-by-year Free Cash Flow Generation Index for KPX Lifescience.Co.Ltd. For the full company profile including market capitalisation, see 114450 market cap.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.12x | ₩62.78 Million | ₩525.49 Million | ₩462.71 Million | ▲ +142.1% |
| 2023 | -0.28x | ₩-105.00 Million | ₩370.02 Million | ₩475.02 Million | ▲ +93.9% |
| 2021 | -4.63x | ₩-2.83 Billion | ₩611.38 Million | ₩3.44 Billion | ▼ -1051.8% |
| 2020 | -0.40x | ₩-765.10 Million | ₩1.90 Billion | ₩2.67 Billion | ▼ -80.9% |
| 2019 | -0.22x | ₩-943.30 Million | ₩4.24 Billion | ₩3.60 Billion | ▼ -109.3% |
| 2018 | 2.39x | ₩12.87 Billion | ₩5.38 Billion | ₩7.49 Billion | ▲ +36.1% |
| 2017 | 1.76x | ₩9.99 Billion | ₩5.68 Billion | ₩4.31 Billion | ▲ +43.3% |
| 2016 | 1.23x | ₩8.67 Billion | ₩7.07 Billion | ₩1.60 Billion | ▲ +12.2% |
| 2015 | 1.09x | ₩6.14 Billion | ₩5.62 Billion | ₩526.82 Million | ▼ -9.3% |
| 2014 | 1.21x | ₩4.92 Billion | ₩4.09 Billion | ₩838.78 Million | — |